Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-19-002292
Filing Date
2019-08-20
Accepted
2019-08-20 17:24:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 5 TO SCHEDULE 13D sc13da510959006_08202019.htm SC 13D/A 94368
  Complete submission text file 0000921895-19-002292.txt   95962
Mailing Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281
Business Address 1275 WEST WASHINGTON STREET SUITE 101 TEMPE AZ 85281 6022865520
Capstone Therapeutics Corp. (Subject) CIK: 0000887151 (see all company filings)

EIN.: 860585310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-42745 | Film No.: 191040597
SIC: 2834 Pharmaceutical Preparations

Mailing Address 122 EAST 42ND STREET SUITE 4305 NEW YORK NY 10168
Business Address 122 EAST 42ND STREET SUITE 4305 NEW YORK NY 10168 212-302-0699
BP Peptides, LLC (Filed by) CIK: 0001711689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE
Type: SC 13D/A